INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,192 | -10.9% | 40,997 | +2.5% | 0.01% | -16.7% |
| Q2 2023 | $2,461 | +27.5% | 40,000 | +14.3% | 0.01% | +20.0% |
| Q1 2023 | $1,930 | +4.6% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,846 | -99.9% | 35,000 | -19.0% | 0.01% | -16.7% |
| Q3 2022 | $1,926,000 | -22.4% | 43,219 | -0.8% | 0.01% | -14.3% |
| Q2 2022 | $2,483,000 | -8.6% | 43,583 | -2.1% | 0.01% | 0.0% |
| Q1 2022 | $2,717,000 | +67.2% | 44,500 | +39.9% | 0.01% | +75.0% |
| Q4 2021 | $1,625,000 | +48.4% | 31,800 | +2.9% | 0.00% | +33.3% |
| Q3 2021 | $1,095,000 | -9.3% | 30,900 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $1,207,000 | +21.6% | 30,900 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $993,000 | +4.2% | 30,900 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $953,000 | +17.5% | 30,900 | -4.6% | 0.00% | 0.0% |
| Q3 2020 | $811,000 | +64.5% | 32,400 | -50.7% | 0.00% | +33.3% |
| Q3 2019 | $493,000 | -70.5% | 65,700 | -50.0% | 0.00% | -62.5% |
| Q2 2019 | $1,670,000 | -14.1% | 131,400 | +47.8% | 0.01% | -33.3% |
| Q1 2019 | $1,945,000 | +124.1% | 88,900 | +11.5% | 0.01% | +100.0% |
| Q4 2018 | $868,000 | -55.4% | 79,700 | -10.3% | 0.01% | -45.5% |
| Q3 2018 | $1,945,000 | +43.5% | 88,900 | +16.7% | 0.01% | +22.2% |
| Q2 2018 | $1,355,000 | -69.1% | 76,200 | -64.3% | 0.01% | -70.0% |
| Q1 2018 | $4,386,000 | +30.8% | 213,200 | -26.3% | 0.03% | +15.4% |
| Q4 2017 | $3,352,000 | 0.0% | 289,200 | 0.0% | 0.03% | 0.0% |
| Q3 2017 | $3,352,000 | -8.6% | 289,200 | 0.0% | 0.03% | -10.3% |
| Q2 2017 | $3,667,000 | -5.7% | 289,200 | +20.9% | 0.03% | -19.4% |
| Q1 2017 | $3,889,000 | +2409.0% | 239,200 | +2292.0% | 0.04% | +1700.0% |
| Q4 2016 | $155,000 | -94.6% | 10,000 | -86.8% | 0.00% | -93.8% |
| Q2 2016 | $2,845,000 | – | 76,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |